Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Increased CDRH Post-Approval Vigilance Plays Out In Medtronic X-Stop Trials

This article was originally published in The Gray Sheet

Executive Summary

Medtronic clinical executive Ruchir Sehra says CDRH's newfound rigor in the postmarket area is evident in its approach to the firm's post-approval study of the X-Stop spinal implant

You may also be interested in...



Analysis: Minimally Invasive Lower-Back Treatments Lack Good Data For Comparison

The scarcity of randomized data for device lower-back pain treatments limits comparisons of their clinical effectiveness and value, researchers conclude in a recent report.

Analysis: Minimally Invasive Lower-Back Treatments Lack Good Data For Comparison

The scarcity of randomized data for device lower-back pain treatments limits comparisons of their clinical effectiveness and value, researchers conclude in a recent report.

Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal

Medtronic is aiming to expand the breadth of its spinal offerings and, in particular, reach a relatively untapped older patient population with its $3.9 billion acquisition of Kyphon, announced July 27 (see chart: "1Medtronic-Kyphon Deal Basics")

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel